Catalog Number 07K70-25 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 11/08/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.(b)(6).This report is being filed on an international product, list number 7k70 that has a similar product distributed in the us, list number 6c06.
|
|
Event Description
|
The customer stated that the architect analyzer generated falsely elevated total psa results on three patient samples.The results provided were on (b)(6) 2016, sid (b)(6): initial = 20.853 / repeat = 0.356ng/ml; sid (b)(6) = 3.245 / 0.046ng/ml; sid (b)(6) = 1.202 / 0.027ng/ml.There was no reported impact to patient management.There was no additional patient information provided.
|
|
Manufacturer Narrative
|
The customer observed potentially falsely elevated total psa results for 3 patients while using architect total psa reagent 7k70-25 lot 67122fn01.A review of complaints determined there are no trends for falsely elevated results for the product.No patient sample was available to assist in the investigation.Accuracy testing of a serum based panel sample, which mimics a patient sample, was performed using a retained kit of lot 67122fn01.All specifications were met indicating that lot 67122fn01 is performing acceptably.A review of the manufacturing documentation of lot 67122fn01 did not identify any issues associated with the customer observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on this investigation the architect total psa, list number 7k70-25, lot 67122fn01, performed as intended and no product deficiency was identified.
|
|
Manufacturer Narrative
|
The device evaluation was reassessed and concluded that a malfunction occurred, therefore the device was not performing as intended.
|
|
Search Alerts/Recalls
|